Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Audioverbal cognitive dysfunction in depression. Factors involved.

Mauro Garcia-Toro1, Juan Antonio Talavera, Elena Gonzalez

  • 1Unidad de Psiquiatría, Hospital Son Llàtzer, Ctra de Manacor Km 4, Palma de Mallorca 07198, Spain. mgarciat@hsll.es

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 29, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency Department Management of Perinatal Substance Use Disorder: Discussing Gaps and Opportunities for Resident Education.

Annals of emergency medicine·2026
Same author

The Direct and Individual Transcriptional Function of the Human Homodimeric and Heterodimeric Basic Helix-Loop-Helix Transcription Factors E47 and Scleraxis.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

[Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022]

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2024
Same author

Human parvovirus B19 vertical infection and hydrops fetalis. A case report.

Archivos argentinos de pediatria·2024
Same author

Prevalence of anterior uveitis in cases of systemic inflammatory response syndrome in dogs and cats.

Veterinary ophthalmology·2024
Same author

Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.

Cancers·2024

Cognitive dysfunction is common in nonmelancholic depression and persists after treatment. Attention may improve with specific antidepressants like sertraline, unlike imipramine, suggesting medication influences cognitive function.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Depression is increasingly linked to cognitive dysfunction, but its persistence and medication influence remain debated.
  • Existing research lacks clarity on whether cognitive deficits are exclusive to severe depression or improve with treatment.

Purpose of the Study:

  • To investigate cognitive dysfunction in untreated patients with dysthymia or non-melancholic major depressive disorder.
  • To assess the impact of clinical response and psychotropic medications on attention and working memory.
  • To explore the role of illness duration in cognitive changes during depression treatment.

Main Methods:

  • Assessed 40 untreated patients and 20 healthy controls using vocal reaction time (VRT), inverse spelling (IS), and text repetition (TR) tasks.

Related Experiment Videos

  • Re-assessed all participants after 2 months, with patients commencing antidepressant treatment.
  • Stratified patient data by illness duration and medication type (sertraline vs. imipramine).

    • Main Results:

    • Patients exhibited longer VRT at baseline compared to controls; VRT did not improve with general treatment response.
    • Sertraline showed a greater VRT improvement than imipramine, independent of overall antidepressant response.
    • Inverse spelling and text repetition performance remained impaired, with some improvement in IS for those with <10 years of illness duration.

    Conclusions:

    • Non-melancholic depression is characterized by persistent cognitive dysfunction, even after clinical improvement.
    • Attention deficits in depression appear influenced by the specific antidepressant medication used.
    • Illness duration may play a role in the trajectory of cognitive changes in depressive disorders.